Definium Therapeutics to release Phase 3 MDD study results June 22
Tweet Send to a Friend
Definium Therapeutics (NASDAQ: DFTX) announced it will host a webcast on June 22, 2026, at 8:00 a.m. EDT to discuss ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
